Putnam Investments’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
Sell
-58,340
Closed -$1.79M 1316
2016
Q2
$1.79M Sell
58,340
-15,596
-21% -$477K ﹤0.01% 964
2016
Q1
$2.77M Sell
73,936
-88,257
-54% -$3.3M 0.01% 859
2015
Q4
$7M Sell
162,193
-1,629
-1% -$70.3K 0.02% 558
2015
Q3
$6.14M Sell
163,822
-175
-0.1% -$6.56K 0.01% 599
2015
Q2
$5.57M Buy
163,997
+10,202
+7% +$347K 0.01% 689
2015
Q1
$5.44M Sell
153,795
-1,595
-1% -$56.5K 0.01% 754
2014
Q4
$5.29M Sell
155,390
-70,304
-31% -$2.39M 0.01% 756
2014
Q3
$8.71M Sell
225,694
-3,351
-1% -$129K 0.02% 529
2014
Q2
$8.91M Buy
229,045
+96,120
+72% +$3.74M 0.02% 519
2014
Q1
$4.55M Sell
132,925
-1,065
-0.8% -$36.4K 0.01% 796
2013
Q4
$2.81M Sell
133,990
-19,300
-13% -$405K 0.01% 955
2013
Q3
$3.6M Hold
153,290
0.01% 853
2013
Q2
$4.12M Buy
+153,290
New +$4.12M 0.01% 784